Integra LifeSciences (IART) | Stock Overview & Key Data
Integra LifeSciences Performance Comparison
Stock Range
Today's Range
Low: $14.97
High: $15.44
on September 12, 2025
52 Week Range
Low: $11.06
High: $27.13
on June 23, 2025
on January 30, 2025
All-Time High: $77.40 on April 26, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.2B
EPS
-6.54
P/E Ratio (TTM)
66.48
Forward P/E
5.98
P/B Ratio
1.13
PEG Ratio
5.98
Div. Yield
N/A
ROE
-38.92%
Beta
1.200
Debt to Equity
194.07
Financial Highlights
Profitability
Gross Margin
50.37%
Operating Margin
7.86%
Profit Margin
-30.87%
Returns and Earnings
Return on Assets (TTM)
2.43%
Return on Equity (TTM)
-38.92%
EBITDA
$179.2M
Net Income (TTM)
$-500.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$21.02
Quarterly Revenue Growth (YoY)
-0.60%
Quarterly Earnings Growth (YoY)
-0.61%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Integra LifeSciences IART | 1.17B Small-cap | -5.82% | 9.37% | 18.68% | -32.28% | -34.58% | -13.80% | -66.94% | -67.70% |
| Abbott Laboratories ABT | 232.75B Mega-cap | 0.59% | 2.07% | -1.99% | 2.65% | 17.89% | 14.93% | 28.63% | 25.19% |
| Boston Scientific BSX | 152.19B Large-cap | -4.21% | 0.07% | 4.21% | 6.52% | 14.91% | 23.30% | 146.33% | 166.94% |
| QuidelOrtho QDEL | 1.94B Small-cap | -0.38% | 13.42% | -4.38% | -22.51% | -36.57% | -37.17% | -65.06% | -84.91% |
| Artivion AORT | 1.92B Small-cap | -6.42% | -7.18% | 41.61% | 73.27% | 44.94% | 61.07% | 93.02% | 134.00% |
| Enovis ENOV | 1.81B Small-cap | -1.28% | 10.33% | -1.77% | -12.81% | -28.40% | -26.81% | -38.16% | -44.90% |
Ownership & Short Interest
Insider Ownership
13.97%
Institutional Ownership
95.31%
Shares Short
7M
Short Ratio
4.79
Short % of Shares Outstanding
15.01%
Average 10-Day Volume
1M
Average 90-Day Volume
1M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is IART's 52-week high and low?
- In the last 52 weeks, Integra LifeSciences reached a high of $27.13 (on January 30, 2025) and a low of $11.06 (on June 23, 2025).
- What is the market cap and P/E ratio for IART?
- Curious about Integra LifeSciences's size and valuation? Its market capitalization stands at 1.17B. When it comes to valuation, the P/E ratio (trailing twelve months) is 66.48, and the forward P/E (looking ahead) is 5.98.
- Does IART pay dividends? If so, what's the yield?
- As for dividends, Integra LifeSciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Integra LifeSciences's main competitors or similar companies to consider before investing?
When looking at Integra LifeSciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT232.75B Healthcare Medical Devices 14.93% 28.63% Boston Scientific
BSX152.19B Healthcare Medical Devices 23.30% 146.33% QuidelOrtho
QDEL1.94B Healthcare Medical Devices -37.17% -65.06% Artivion
AORT1.92B Healthcare Medical Devices 61.07% 93.02% Enovis
ENOV1.81B Healthcare Medical Devices -26.81% -38.16% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Integra LifeSciences Holdings Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Integra LifeSciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -38.92%, the Debt to Equity ratio from the most recent quarter is 194.07, and its Gross Profit Margin stands at 50.37%.
- What is the recent revenue and earnings growth for IART?
- Looking at Integra LifeSciences's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by -0.60%, and quarterly earnings saw a YoY growth of -0.61%.
- How much of IART stock is held by insiders and institutions?
- Wondering who owns Integra LifeSciences stock? Company insiders (like executives and directors) hold about 13.97% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 95.31%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.